Sanofi to buy Kadmon for $1.9B, extending deal streak
Sanofi has agreed to buy Kadmon Holdings for $1.9 billion, the latest in a string of acquisitions the French pharmaceutical giant has used to add new drugs and techno...
Continue Reading →
